Product
Homepage
/
/
Borane products
/
Organic Borane Compound
/
9-Borabicyclo[3.3.1]nonane

Borane products

All categories

Organic Borane Compound

(+)-Diisopinocampheyl Chloroborane (60% in Heptane)
(+)-Diisopinocampheyl Chloroborane (60% in Heptane)
(+)-Diisopinocampheyl Chloroborane (60% in Heptane)
More 白箭头 黑箭头
(-)-Diisopinocampheyl Chloroborane (60% in Heptane)
(-)-Diisopinocampheyl Chloroborane (60% in Heptane)
(-)-Diisopinocampheyl Chloroborane (60% in Heptane)
More 白箭头 黑箭头
(R)-(+)-α,α-Diphenylprolinol
(R)-(+)-α,α-Diphenylprolinol
(R)-(+)-α,α-Diphenylprolinol
More 白箭头 黑箭头
(R)-2-Methyl-CBS-oxazaborolidine (1.0M in Toluene)
(R)-2-Methyl-CBS-oxazaborolidine (1.0M in Toluene)
(R)-2-Methyl-CBS-oxazaborolidine (1.0M in Toluene)
More 白箭头 黑箭头
(S)-(-)-α,α-Diphenylprolinol
(S)-(-)-α,α-Diphenylprolinol
(S)-(-)-α,α-Diphenylprolinol
More 白箭头 黑箭头
(S)-2-Methyl-CBS-oxazaborolidine (1.0M in Toluene)
(S)-2-Methyl-CBS-oxazaborolidine (1.0M in Toluene)
(S)-2-Methyl-CBS-oxazaborolidine (1.0M in Toluene)
More 白箭头 黑箭头
1-(Tetrahydropyran-2-yl)-1h-pyrazole-5-boronic Acid Pinacol Ester
1-(Tetrahydropyran-2-yl)-1h-pyrazole-5-boronic Acid Pinacol Ester
1-(Tetrahydropyran-2-yl)-1h-pyrazole-5-boronic Acid Pinacol Ester
More 白箭头 黑箭头
2-Chloro-3-fluorophenylboronic Acid
2-Chloro-3-fluorophenylboronic Acid
2-Chloro-3-fluorophenylboronic Acid
More 白箭头 黑箭头
2-Fluoro-6-hydroxybenzeneboronic Acid Pinacol Ester
2-Fluoro-6-hydroxybenzeneboronic Acid Pinacol Ester
2-Fluoro-6-hydroxybenzeneboronic Acid Pinacol Ester
More 白箭头 黑箭头
5-Ethyl-2-methylpyridine Borane
5-Ethyl-2-methylpyridine Borane
5-Ethyl-2-methylpyridine Borane
More 白箭头 黑箭头
9-Borabicyclo[3.3.1]nonane
9-Borabicyclo[3.3.1]nonane
9-Borabicyclo[3.3.1]nonane
More 白箭头 黑箭头
B-Methoxy-9-borabicyclo[3.3.1]nonane
B-Methoxy-9-borabicyclo[3.3.1]nonane
B-Methoxy-9-borabicyclo[3.3.1]nonane
More 白箭头 黑箭头
Borane 2-Picoline Complex
Borane 2-Picoline Complex
Borane 2-Picoline Complex
More 白箭头 黑箭头
Borane Ammonia Complex
Borane Ammonia Complex
Borane Ammonia Complex
More 白箭头 黑箭头
Borane Dimethylamine Complex
Borane Dimethylamine Complex
Borane Dimethylamine Complex
More 白箭头 黑箭头
Borane Dimethylsulfide Complex
Borane Dimethylsulfide Complex
Borane Dimethylsulfide Complex
More 白箭头 黑箭头
Borane Morpholine Complex
Borane Morpholine Complex
Borane Morpholine Complex
More 白箭头 黑箭头
Borane Pyridine Complex
Borane Pyridine Complex
Borane Pyridine Complex
More 白箭头 黑箭头
Borane Tert-Butylamine Complex
Borane Tert-Butylamine Complex
Borane Tert-Butylamine Complex
More 白箭头 黑箭头
Borane Tertmethylamine Complex
Borane Tertmethylamine Complex
Borane Tertmethylamine Complex
More 白箭头 黑箭头
Previous page
1
2

News Center

Viwit’s Levetiracetam Tablets Approved by FDA 2024-04-09 11:28:41
On April 5, 2024, Viwit Pharmaceuticals' Levetiracetam Tablets received an Approval Letter (#078869) from the U.S. Food and Drug Administration (FDA), marking Viwit's first approved oral solid dosage in the United States.
Viwit Pharmaceuticals' Mirabegron API Receives Official Approval by China NMPA 2024-01-26 11:09:29
On January 23, 2024, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by China National Medical Products Administration (NMPA) for its own proprietary active pharmaceutical ingredient (API) Mirabegron, developed independently. The issued registration number is Y20220000096, and the corresponding notice number is 2024YS00039.
Viwit Pharmaceuticals' Vildagliptin Tablets Receive Official Approval by China NMPA 2023-12-22 13:19:44
Viwit Pharmaceuticals is pleased to announce the acquisition of the Drug Registration Certificate (Certificate No: 2023S01974) from the National Medical Products Administration (NMPA) for a proprietary finished dosage form, Vildagliptin tablet. This signifies the official approval of this product in the Chinese market.
Viwit Pharmaceuticals' Lidocaine Injection Receives Official Approval by China NMPA 2023-12-19 11:25:05
On December 18, 2023, Viwit Pharmaceuticals received the "Drug Supplementary Application Approval Notice" (Notice No: 2023B06224) issued by the China National Medical Products Administration for a proprietary finished dosage form, Lidocaine Hydrochloride for Injection (5ml: 0.1g).
Viwit Pharmaceuticals' Vildagliptin API Receives Official Approval by China NMPA 2023-12-07 08:31:28
On November 30, 2023, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by National Medical Products Administration (NMPA) for its independently developed active pharmaceutical ingredient (API), Vildagliptin. The registration number is Y20210000619, and the notice number is 2023YS00803.
Viwit Pharmaceuticals' Aprepitant API Receives Official Approval by China NMPA 2023-10-31 15:33:57
On October 26, 2023, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by China National Medical Products Administration (NMPA) for the independently developed active pharmaceutical ingredient (API) Aprepitant. The registration number is Y20210000473, and the notice number is 2023YS00727.

9-Borabicyclo[3.3.1]nonane

Product Name : 9-Borabicyclo[3.3.1]nonane
CAS# : 280-64-8
产品描述
Parameters

Molecular Formula

 C8H15B

Molecular Weight

 122.02

Molecular Structure

Product Description

 Colorless to light yellow liquid;
Concentration: 0.48 mol/L -0.52 mol/L;
A borohydride agent and has high selectivity when reacting with olefins. Under controlled conditions, it can react only with double bonds with small steric hindrance.

Packing Size

170.00 kg/pack;
150.00 kg/pack;
100.00 kg/pack;
40.00 kg/pack;
20.00 kg/pack;
10.00 kg/pack;

Or pack as per customer requirement

Storage Conditions 

 Store at ventilated and dry place.
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
Previous
Trimethylboroxine (50% in THF)
Next
Borane Triethylamine Complex
search
Confirm
Close
About Us
Company Introduction Corporate History Business Introduction Corporate Governance Company Culture Corporate Honors Viwit Family Media Center Video
R&D and Innovation
R&D Innovation Product Pipeline Achievements
Products
Drug Products Biologics APIs Intermediates Boranes
Innovation
CDMO Project Collaboration In-/Out-Licensing Joint Venture
Sustainable
EHS Energy Quality Supplier
News Center
In 2024 In 2023 In 2022 In 2021 In 2020 In 2019 In 2018 In 2017 In 2016
Join Us
Talent Philosophy Talent Development Salary and Benefits Campus Recruiting Social Recruitment
Contact Us
Online Message Contact Us
News Center
dp EN
dp 中文

wz

wz